LSE:AZN (AstraZeneca PLC)
About AZN
AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
AstraZeneca PLC (LSE: AZN) Latest News
Investing Articles
2 ‘hidden’ AI stocks in the FTSE 100
Investing Articles
Should investors buy AstraZeneca shares after a 16% pullback?
Investing Articles
9 stocks that Fools have been buying!
Investing Articles
2 high-scoring UK quality stocks to consider immediately
Investing Articles
Cancer pipeline to power future gains for AstraZeneca shares?
Investing Articles
The largest FTSE 100 stock just fell 8%! Should investors buy?
Investing Articles
Will rumours of a separate listing damage AstraZeneca’s share price?
Investing Articles
Here’s what I’d have now by investing £1,000 in AstraZeneca shares 5 years ago
Investing Articles
If I’d invested £10,000 in AstraZeneca shares one year ago, here’s what I’d have now!
Investing Articles
If I could only buy 1 FTSE 100 stock, I’d put 100% of my money into this one
Investing Articles
Is now the time to buy this FTSE 100 outperformer on the dip?